drugset
drugset / Trial / NCT00948805

Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment

NCT00948805 ↗

Phase 3 Unknown 25 enrolled University of Sao Paulo
RandomizedSingle-groupOpen-labelTreatment

Summary

This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh) agonist to prevent the rise of progesterone during controlled ovarian stimulation for in vitro fertilization (IVF) after the administration of human Chorionic Gonadotropin (hCG) on the first day of menses.

Timeline

Start
2009-01
Primary completion
2009-12
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified 3.6 mg —
Background FSH Unknown 150 iu —
Background human chorionic gonadotropin Protein / enzyme biologic 250 mg —

Indications

infertility disorder